IP Library › Granted Patent US 12,252,658
Granted Patent B2
US 12,252,658 · App. 18/511,809 · Granted Mar 18, 2025

Durable surface coatings

Inventors: Hussain Rangwala (Villa Park, CA); William R. Patterson (Huntington Beach, CA); Aaron Baldwin (Orange, CA)
Assignee: MicroVention, Inc.
C10M111/04C10M105/76C10M107/42C10M177/00C10M2217/0245C10M2227/045C10N2040/50C10N2050/023C10N2070/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,252,658
App. No.
18/511,809
Granted
Mar 18, 2025
Kind
B2
Abstract

Described herein are durable coatings, i.e. for medical devices, and methods of forming the coatings.

Claims (29)

1. A method of accessing a lumen of a subject, comprising inserting a medical device into the subject, the medical device including a surface on which a coating is disposed,

wherein the coating comprises a base coat and a top coat covalently linked to the base coat, wherein the base coat includes an alkylsilanyl moiety, and the top coat includes a polymeric moiety having an amine moiety, wherein the coating is about 100 nanometers thick or less.

2. The method of claim 1 , wherein the coating is covalently linked to the surface.

3. The method of claim 1 , wherein the polymeric moiety is a poly (MEA-CO-APMA) polymer, an amine functionalized poly(ethylene glycol) polymer, an amine functionalized poly(vinyl alcohol), an amine functionalized hyaluronic acid, or a combination thereof.

4. The method of claim 1 , wherein the alkylsilanyl moiety is (C 1-20 alkyl) silanyl.

5. The method of claim 1 , wherein the alkylsilanyl moiety is propylsilanyl, propylmethoxysilanyl, propyldimethoxysilanyl, heptylsilanyl, heptylmethoxysilanyl, heptyldimethoxysilanyl, undecylsilanyl, undecylmethoxysilanyl, undecyldimethoxysilanyl, or a combination thereof.

6. The method of claim 1 , wherein the base coat and top coat are covalently linked such that an aminoalkylsilanyl moiety is present.

7. The method of claim 1 , wherein the amine moiety is a secondary amine or a tertiary amine.

8. The method of claim 1 , wherein the coating is about 10 nanometers thick or less.

9. The method of claim 1 , wherein the coating is about 1 nanometer thick.

10. The method of claim 1 , wherein the coating is covalently linked to the surface of the medical device.

11. The method of claim 1 , wherein the coating is disposed on the surface of the medical device by a process for forming the coating,

wherein the process comprises contacting the alkylsilanyl moiety with the polymeric moiety having an amine moiety to form the coating, and

wherein the alkylsilanyl moiety is a haloalkylsilanyl moiety.

12. The method of claim 11 , wherein the haloalkylsilanyl moiety is halopropylsilanyl, halopropylmethoxysilanyl, halopropyldimethoxysilanyl, haloheptylmethoxysilanyl, haloheptyldimethoxysilanyl, haloheptylsilanyl, haloundecylsilanyl, haloundecylmethoxysilanyl, haloundecyldimethoxysilanyl, or a combination thereof.

13. The method of claim 12 , wherein the halo is bromo.

14. The method of claim 1 , wherein the coating is disposed on the surface of the medical device by a process for coating the medical device, including:

a) contacting a halosilanyl compound with the surface of the medical device to form the base coat; and

b) contacting the base coat with the polymeric moiety having an amine moiety, which is a hydrophilic polymeric moiety having an amine moiety, to form the top coat,

wherein the base coat is covalently linked to the surface of the medical device, and the top coat is covalently linked to the base coat, and

wherein a combined thickness of the base coat and top coat is about 100 nanometers or less.

15. The method of claim 14 , wherein the halosilanyl compound is 3-bromopropyltrimethoxysilane, 7-bromoheptyltrimethoxysilane, 11-bromoundecyltrimethoxysilane, or a combination thereof.

16. The method of claim 14 , wherein the process is performed with the surface of the medical device at least partially submerged in a solution.

17. The method of claim 14 , further comprising a curing step subsequent to forming the base coat and prior to forming the top coat.

18. The method of claim 14 , further comprising contacting the surface of the medical device with a hydroxylating agent prior to forming the base coat.

19. The method of claim 1 , wherein the base coat is covalently linked to the surface.

20. The method of claim 11 , wherein the alkylsilanyl moiety is a bromo silane, and the polymeric moiety having an amine moiety is a copolymer of 2-methoxyethyl acrylate and N-(3-aminopropyl) methacrylamide.

21. The method of claim 11 , wherein the alkylsilanyl moiety is 3-bromopropyltrimethoxysilane, and the polymeric moiety having an amine moiety is a copolymer of 2-methoxyethyl acrylate and N-(3-aminopropyl) methacrylamide.

22. The method of claim 1 , wherein the coating comprises the structure

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2023
From: RANGWALA, HUSSAIN; PATTERSON, WILLIAM R.; BALDWIN, AARON
To: MICROVENTION, INC.
Reel/Frame 065591/0336 →
Continuity (3)
Continuation 17396471 · Aug 6, 2021
Provisional Application 63062995 · Aug 7, 2020
Related Publication 20240084210A1 · Mar 14, 2024
References Cited (86)
US 4378430A · Modrovich · 1983 [cited by applicant]
US 4459317A · Lambert · 1984 [cited by applicant]
US 4465770A · Modrovich · 1984 [cited by applicant]
US 4487808A · Lambert · 1984 [cited by applicant]
US 4842597A · Brook · 1989 [cited by applicant]
US 5077352A · Elton · 1991 [cited by applicant]
US 5164321A · Zdunek et al. · 1992 [cited by applicant]
US 5225267A · Ochi et al. · 1993 [cited by applicant]
US 5281468A · Klier et al. · 1994 [cited by applicant]
US 5545208A · Wolff et al. · 1996 [cited by applicant]
US 5662960A · Hostettler et al. · 1997 [cited by applicant]
US 5736251A · Pinchuk · 1998 [cited by examiner]
US 5753453A · Kwan · 1998 [cited by applicant]
US 5776661A · Casaletto et al. · 1998 [cited by applicant]
US 5804299A · Nakata et al. · 1998 [cited by applicant]
US 5888656A · Suzuki et al. · 1999 [cited by applicant]
US 6030656A · Hostettler et al. · 2000 [cited by applicant]
US 6083257A · Taylor et al. · 2000 [cited by applicant]
US 6099562A · Ding et al. · 2000 [cited by applicant]
US 6673453B2 · Beavers et al. · 2004 [cited by applicant]
US 6706408B2 · Jelle · 2004 [cited by examiner]
US 6803069B2 · Patnaik et al. · 2004 [cited by applicant]
US 7008979B2 · Schottman et al. · 2006 [cited by applicant]
US 7264859B2 · Rouns et al. · 2007 [cited by applicant]
US 7494687B2 · Cox · 2009 [cited by applicant]
US 7544381B2 · Kangas · 2009 [cited by applicant]
US 7544673B2 · DeWitt et al. · 2009 [cited by applicant]
US 7553546B1 · Tan · 2009 [cited by applicant]
US 7770828B2 · Matsumoto et al. · 2010 [cited by applicant]
US 8263720B1 · Salamone et al. · 2012 [cited by applicant]
US 10543299B2 · Baldwin et al. · 2020 [cited by applicant]
US 11188869B2 · Subramaniam et al. · 2021 [cited by applicant]
US 11278649B2 · Baldwin et al. · 2022 [cited by applicant]
US 11744925B2 · Cruise et al. · 2023 [cited by applicant]
US 11783278B2 · Subramaniam et al. · 2023 [cited by applicant]
US 11827862B2 · Rangwala et al. · 2023 [cited by applicant]
US 20010021745A1 · Laginess et al. · 2001 [cited by applicant]
US 20020082679A1 · Sirhan et al. · 2002 [cited by applicant]
US 20020094322A1 · Lawson et al. · 2002 [cited by applicant]
US 20020120033A1 · Jia et al. · 2002 [cited by applicant]
US 20030069647A1 · Desmond et al. · 2003 [cited by applicant]
US 20030187493A1 · Campbell et al. · 2003 [cited by applicant]
US 20050055044A1 · Kangas · 2005 [cited by applicant]
US 20060052757A1 · Fischer et al. · 2006 [cited by applicant]
US 20060121217A1 · Childs et al. · 2006 [cited by applicant]
US 20060251795A1 · Kobrin et al. · 2006 [cited by applicant]
US 20070154703A1 · Waller et al. · 2007 [cited by applicant]
US 20090076596A1 · Adden et al. · 2009 [cited by applicant]
US 20090112239A1 · To · 2009 [cited by applicant]
US 20090297607A1 · Wang et al. · 2009 [cited by applicant]
US 20090324666A1 · Krongauz et al. · 2009 [cited by applicant]
US 20100105799A1 · Rudd et al. · 2010 [cited by applicant]
US 20100113871A1 · Dias et al. · 2010 [cited by applicant]
US 20100198168A1 · Rooijmans · 2010 [cited by applicant]
US 20100236684A1 · Garlough · 2010 [cited by applicant]
US 20110000788A1 · Deschamps et al. · 2011 [cited by applicant]
US 20110117282A1 · Bernard et al. · 2011 [cited by applicant]
US 20110151000A1 · Schultz et al. · 2011 [cited by applicant]
US 20110160382A1 · Pacetti · 2011 [cited by applicant]
US 20110183867A1 · Davies et al. · 2011 [cited by applicant]
US 20130243936A1 · Garretson et al. · 2013 [cited by applicant]
US 20130261566A1 · Lockwood et al. · 2013 [cited by applicant]
US 20140011928A1 · Iwasawa et al. · 2014 [cited by applicant]
US 20180093019A1 · Baldwin et al. · 2018 [cited by applicant]
US 20180325649A1 · Wu et al. · 2018 [cited by applicant]
US 20190201589A1 · Farrell et al. · 2019 [cited by applicant]
US 20200157374A1 · Nakabayashi · 2020 [cited by applicant]
US 20220162470A1 · Wu et al. · 2022 [cited by applicant]
US 20230303743A1 · Cruise et al. · 2023 [cited by applicant]
US 20230381380A1 · Cruise et al. · 2023 [cited by applicant]
WO 2008104573A2 · 2008 [cited by applicant]
WO 2013130850A1 · 2013 [cited by applicant]
WO 2017158148A1 · 2017 [cited by applicant]
WO 2020159881A1 · 2020 [cited by applicant]
WO 2021021642A1 · 2021 [cited by applicant]
WO 2022026689A1 · 2022 [cited by applicant]
Bruice, Acid-Base Properties of Amino Acids. Organic Chemistry, Fifth Edition (textbook), Pearson Education Inc., p. 1025 (2007). [cited by applicant]
Weber, Use of ionic and zwitterionic (Tris/Bis Tris and HEPES) buffers in studies on hemoglobin function. J. Appl. Physiol., 72(4):1611-1615 (1992). [cited by applicant]
Tsai et al., Dopamine-assisted immobilzation of poly(ethylene imine) based polymers for control of cell-surface interactions. Acta Biomaterialia 7, pp. 2518-2525 (2011). [cited by applicant]
Nagaoka et al., “Low friction hydrophilic surface for medical devices,” Journal of Bioactive and Compatible Polymers, 5:212-226 (1990). [cited by applicant]
Vijay et al., “Acrylic acid-methyl methacrylate copolymer for oral prolonged drug release,” J Mater Sci: Mater Med, 2010, 21, 2583-2592. (Year: 2010). [cited by applicant]
Zhu et al., “Polysulfone hemadiafiltration membranes with enhanced anti-fouling and hemocompatibility modified by poly(vinyl pyrrolidone) via in situ cross-linked polymerization,” Material Science and Engineering C 74, … [cited by applicant]
International Search Report and Written Opinion, dated May 30, 2013, for International Application No. PCT/US2013/028380 filed on Feb. 28, 2013. [cited by applicant]
International Search Report and Written Opinion, dated Apr. 14, 2020, for International Application No. PCT/US2020/015240 filed on Jan. 27, 2020. [cited by applicant]
International Search Report and Written Opinion, mailed Oct. 26, 2020, for International Application No. PCT/US2020/043528 filed on Jul. 24, 2020. [cited by applicant]
International Search Report and Written Opinion, dated Nov. 2, 2021, for International Application No. PCT/US2021/043677 filed on Jul. 29, 2021. [cited by applicant]